Patients with Atrial Fibrillation are Unlikely to Benefit from Aspirin Monotherapy.

ASA monotherapy is not associated with a lower risk of ischemic events, while significantly associated with a higher risk of bleeding events. Patients with AF are unlikely to benefit from aspirin monotherapy.